3

PRIMARY DOCUMENT

Company: PALVELLA THERAPEUTICS, INC.
Filed: September 3, 2019
Period of Report: September 3, 2019
Accession Number: 0001562180-19-004581

View Document ↗ View on SEC.gov ↗